Stoney Lonesome HF LP has disclosed a significant investment in Advanced Flower Capital Inc., holding approximately 7.4% of the company's outstanding shares. This filing, made on November 13, 2026, underlines the growing interest in the cannabis finance sector, particularly as companies like Advanced Flower Capital continue to expand their operations.
Advanced Flower Capital Inc. is a Maryland-based company that focuses on providing financing solutions for the cannabis industry. The recent filing indicates that Stoney Lonesome HF LP directly beneficially owns 1,654,601 shares of Advanced Flower Capital, which reflects a strategic move in a rapidly evolving market.
Background
Stoney Lonesome HF LP is a Delaware limited partnership. The company has been active in filing various reports with the SEC, including multiple Schedule 13G/A filings this year. As of November 2026, the company has made several disclosures regarding its ownership stakes, reflecting its ongoing investment strategy.
What the Filing Says
The recent Schedule 13G/A filing reveals that Stoney Lonesome HF LP, along with its affiliates, holds a substantial stake in Advanced Flower Capital Inc. The filing states, "As of the close of business on September 30, 2026, Stoney Lonesome beneficially owned approximately 7.4% of the outstanding Shares." This positions Stoney Lonesome as a notable player in the cannabis finance sector.
Impact
This disclosure may impact various stakeholders, including investors, competitors, and market analysts. The significant ownership by Stoney Lonesome HF LP suggests a growing confidence in the cannabis finance market, which could prompt other firms to reassess their positions and strategies. The filing also highlights the involvement of other entities such as Coghill Capital Management LLC and CDC Financial, which may influence market dynamics.
What's Next
The filing does not specify what happens next for Stoney Lonesome HF LP or Advanced Flower Capital Inc. However, the continued investment activity in this sector indicates that further developments may be on the horizon.
For more details, refer to the SEC filing with accession number 0000921895-26-003107.
Read Next
Oaktree Capital Management Updates Stake in Quantum Corporation
Morgan Stanley Reduces Stake in MIND CTI LTD to Below 5%
Morgan Stanley Updates Ownership in Kayne Anderson Fund
Great Lakes Advisors Increases Stake in American Century ETF Trust
ST-1014 Fund I acquires 9.6% stake in Standard Nuclear
TD Securities Discloses 4.6% Stake in OneMedNet Corp




